Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo

Endocrinology

Volumn 146, Issue 4, 2005, Pages 1772-1779

  Kim, Hyunsook ^a   Barton, Elisabeth ^c   Muja, Naser ^b   Yakar, Shoshana ^a   Pennisi, Patricia ^a   LeRoith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MESSENGER RNA; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HORMONE RESPONSE; IN VIVO STUDY; MALE; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE MASS; MUSCLE STRENGTH; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WILD TYPE;

ANIMALS; GROWTH HORMONE; INSULIN; MALE; MICE; MUSCLE, SKELETAL; RECEPTOR, IGF TYPE 1; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 15444374046     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0906     Document Type: Article

References (47)

1. Daughaday WH, Hall K, Raben MS, Salmon Jr WD, van den Brande JL, van Wyk JJ 1972 Somatomedin: proposed designation for sulphation factor. Nature 235:107
2. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74
3. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
4. Janssen YJ, Doornbos J, Roelfsema F 1999 Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 84:279-284
5. Frost RA, Nystrom GJ, Lang CH 2002 Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts. Endocrinology 143:492-503
6. Chow JC, Ling PR, Qu Z, Laviola L, Ciccarone A, Bistrian BR, Smith RJ 1996 Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137:2880-2886
7. Woelfle J, Chia DJ, Rotwein P 2003 Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation. J Biol Chem 278:51261-51266
8. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72
9. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ 1995 Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 270:12109-12116
10. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL 1998 Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95:15603-15607
11. Sommerland H, Ullman M, Jennische E, Skottner A, Oldfors A 1989 Muscle regeneration. The effect of hypophysectomy on cell proliferation and expression of insulin-like growth factor-I. Acta Neuropathol (Berl) 78:264-269
12. Singleton JR, Feldman EL 2001 Insulin-like growth factor-I in muscle metabolism and myotherapies. Neurobiol Dis 8:541-554
13. Lassar AB, Skapek SX, Novitch B 1994 Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 6:788-794
14. Bailey P, Holowacz T, Lassar AB 2001 The origin of skeletal muscle stem cells in the embryo and the adult. Curr Opin Cell Biol 13:679-689
15. Adams GR 2002 Autocrine and/or paracrine insulin-like growth factor-I activity in skeletal muscle. Clin Orthop S188-S196
16. Fernandez AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, Shulman GI, Le Roith D 2001 Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15:1926-1934
17. Fernandez AM, Dupont J, Farrar RP, Lee S, Stannard B, Le Roith D 2002 Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J Clin Invest 109:347-355
18. Liu JL, Grinberg A, Westphal H, Sauer B, Accili D, Karas M, LeRoith D 1998 Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol 12:1452-1462
19. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220
20. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts Jr CT, LeRoith D 1989 Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 86:7451-7455
21. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
22. Brooks SV, Faulkner JA 1988 Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404:71-82
23. Dupont J, Fernandez AM, Glackin CA, Helman L, LeRoith D 2001 Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the antiapoptotic effects of the IGF-1 receptor. J Biol Chem 276:26699-26707
24. Smith HK, Maxwell L, Rodgers CD, McKee NH, Plyley MJ 2001 Exercise-enhanced satellite cell proliferation and new myonuclear accretion in rat skeletal muscle. J Appl Physiol 90:1407-1414
25. Rosenthal SM, Cheng ZQ 1995 Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts. Proc Natl Acad Sci USA 92:10307-10311
26. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH 1991 Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 70:688-694
27. Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA 1997 Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab 82:2877-2884
28. Andersen NB, Andreassen TT, Orskov H, Oxlund H 2000 Growth hormone and mild exercise in combination increases markedly muscle mass and tetanic tension in old rats. Eur J Endocrinol 143:409-418
29. Weber MM 2002 Effects of growth hormone on skeletal muscle. Horm Res 58(Suppl 3):43-48
30. Bigland B, Jehring B 1952 Muscle performance in rats, normal and treated with growth hormone. J Physiol 116:129-136
31. Goldberg AL, Goodman HM 1969 Relationship between growth hormone and muscular work in determining muscle size. J Physiol 200:655-666
32. Ullman M, Oldfors A 1989 Effects of growth hormone on skeletal muscle. I. Studies on normal adult rats. Acta Physiol Scand 135:531-536
33. Lewis AJ, Wester TJ, Burrin DG, Dauncey MJ 2000 Exogenous growth hormone induces somatotrophic gene expression in neonatal liver and skeletal muscle. Am J Physiol Regul Integr Comp Physiol 278:R838-R844
34. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N 2001 Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200
35. Aroniadou-Anderjaska V, Lemon PW, Gilloteaux J 1996 Effects of exogenous growth hormone on skeletal muscle of young female rats. Tissue Cell 28:719-724
36. Cartee GD, Bohn EE, Gibson BT, Farrar RP 1996 Growth hormone supplementation increases skeletal muscle mass of old male Fischer 344/brown Norway rats. J Gerontol A Biol Sci Med Sci 51:B214-B219
37. Dudley GA, Portanova R 1987 Histochemical characteristics of soleus muscle in hGH transgenic mice. Proc Soc Exp Biol Med 185:403-408
38. Daugaard JR, Laustsen JL, Hansen BS, Richter EA 1998 Growth hormone induces muscle fibre type transformation in growth hormone-deficient rats. Acta Physiol Scand 164:119-126
39. Hodik V, Mett A, Halevy O 1997 Mutual effects of growth hormone and growth factors on avian skeletal muscle satellite cells. Gen Comp Endocrinol 108:161-170
40. Florini JR, Ewton DZ, Coolican SA 1996 Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517
41. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P 2001 Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 276:39264-39270
42. Halevy O, Hodik V, Mett A 1996 The effects of growth hormone on avian skeletal muscle satellite cell proliferation and differentiation. Gen Comp Endocrinol 101:43-52
43. Charlton M, Nair KS 1998 Protein metabolism in insulin-dependent diabetes mellitus. J Nutr 128:323S-327S
44. Garibotto G 1999 Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure. Nutrition 15:145-155
45. Rooyackers OE, Nair KS 1997 Hormonal regulation of human muscle protein metabolism. Annu Rev Nutr 17:457-485
46. Wolfe RR 2000 Effects of insulin on muscle tissue. Curr Opin Clin Nutr Metab Care 3:67-71
47. Willis PE, Chadan S, Baracos V, Parkhouse WS 1997 Acute exercise attenuates age-associated resistance to insulin-like growth factor I. Am J Physiol 272:E397-E404